WVE
Wave Life Sciences Ltd.NASDAQHealthcare$7.28+6.59%ClosedMarket Cap: $1.37B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
2.43
P/S
31.24
EV/EBITDA
-3.74
DCF Value
$0.53
FCF Yield
-14.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
84.5%
Operating Margin
-504.1%
Net Margin
-478.3%
ROE
-85.0%
ROA
-32.0%
ROIC
-39.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $17.2M | 86.9% | $-56.5M | $-53.2M | $-0.30 | — |
| FY 2025 | $42.7M | 79.3% | $-215.4M | $-204.4M | $-1.21 | — |
| Q3 2025 | $7.6M | 100.0% | $-56.4M | $-53.9M | $-0.32 | — |
| Q2 2025 | $8.7M | 74.8% | $-52.8M | $-50.5M | $-0.31 | — |
| Q1 2025 | $9.2M | 76.4% | $-49.8M | $-46.9M | $-0.29 | — |
| Q4 2024 | $83.7M | 100.0% | $23.0M | $29.3M | $0.17 | — |
| FY 2024 | $108.3M | 100.0% | $-110.4M | $-97.0M | $-0.70 | — |
| Q3 2024 | $-7.7M | 100.0% | $-63.9M | $-61.8M | $-0.47 | — |
| Q2 2024 | $19.7M | 100.0% | $-35.0M | $-32.9M | $-0.25 | — |
| Q1 2024 | $12.5M | 100.0% | $-34.5M | $-31.6M | $-0.24 | — |
| Q4 2023 | $29.1M | 92.5% | $-18.7M | $-16.3M | $-0.15 | — |
| FY 2023 | $113.3M | 100.0% | $-68.0M | $-57.5M | $-0.54 | — |